At-risk phenotype of neurofibromatose-1 patients: A multicentre case-control study

Orphanet Journal of Rare Diseases

Volumn 6, Issue 1, 2011, Pages

  Sbidian, Emilie ^a,b   Bastuji Garin, Sylvie ^a,b   Valeyrie Allanore, Laurence ^a,b   Ferkal, Salah ^b,c   Lefaucheur, Jean P ^a,b   Drouet, Alain ^d,e   Brugière, Pierre ^b   Vialette, Cédric ^b   Combemale, Patrick ^e   Barbarot, Sébastien ^f   Wolkenstein, Pierre ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c INSERM   (France)

^d HIA Desgenettes   (France)

^e CENTRE LÉON BÉRARD   (France)

^f HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIVARIATE ANALYSIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; FEMALE; HOSPITAL; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MULTICENTER STUDY; NERVE CONDUCTION; NERVE ROOT TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NEUROPATHY; PHENOTYPE; PROSPECTIVE STUDY; REVIEW; SCIATIC NERVE; SPINAL CORD; SUBCUTANEOUS TISSUE TUMOR; ARTICLE; CLINICAL TRIAL; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SKIN TUMOR; SUBCUTANEOUS TISSUE;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROFIBROMA; NEUROFIBROMATOSIS 1; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENOTYPE; PROSPECTIVE STUDIES; SKIN NEOPLASMS; SUBCUTANEOUS TISSUE;

EID: 79960117265     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-6-51     Document Type: Review

References (14)

1. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. SA Rasmussen, Q Yang, JM Friedman, Am J Hum Genet 2001 68 5 1110 8 10.1086/320121 11283797 (Pubitemid 32424410)
2. Neurofibromatosis: phenotype, natural history, and pathogenesis. VM Riccardi, Johns Hopkins University Press 1992
3. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. JM Woodruff, Am J Med Genet 1999 26 89 23 30 (Pubitemid 30033173)
4. Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients. K Khosrotehrani, S Bastuji-Garin, J Zeller, J Revuz, P Wolkenstein, Arch Dermatol 2003 139 2 187 91 10.1001/archderm.139.2.187 12588224 (Pubitemid 36216256)
5. Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients. K Khosrotehrani, S Bastuji-Garin, VM Riccardi, P Birch, JM Friedman, P Wolkenstein, Am J Med Genet A 2005 132A 1 49 53 10.1002/ajmg.a.30394 15523617 (Pubitemid 40070560)
6. NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1. E Sbidian, P Wolkenstein, L Valeyrie-Allanore, D Rodriguez, S Hadj-Rabia, S Ferkal, JP Lacour, JC Leanoard, L Taillandier, S Sportich, P Berbis, S Bastuji-Garin, J Invest Dermatol 2010 130 9 2173 8 10.1038/jid.2010.100 20428190
7. Neurofibromatosis 1-associated neuropathies: a reappraisal. A Drouet, P Wolkenstein, JP Lefaucheur, S Pinson, P Combemale, RK Gherardi, et al. Brain 2004 127 Pt 9 1993 2009 15289270 (Pubitemid 39150258)
8. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988 45 5 575 8 3128965
9. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991 41 617 18 Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force 2027473
10. NF1 gene and neurofibromatosis 1. SA Rasmussen, JM Friedman, Am J Epidemiol 2000 151 1 33 40 10625171 (Pubitemid 30470392)
11. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1. L Valeyrie-Allanore, N Ismaili, S Bastuji-Garin, J Zeller, J Wechsler, J Revuz, P Wolkenstein, Br J Dermatol 2005 153 1 79 82 10.1111/j.1365-2133.2005.06558.x 16029330 (Pubitemid 41044531)
12. Neurofibromatosis 1: recommendations for management. S Pinson, A Creange, S Barbarot, JF Stalder, Y Chaix, D Rodriguez, M Sanson, A Bernheim, M D'incan, F Doz, C Stoll, P Combemale, C Kalifa, J Zeller, D Teillac-Hamel, S Lyonnet, M Zerah, JP Jacour, B Guillot, P Wolkenstein, Ann Dermatol Venereol 2001 128 4 567 75 11395662
13. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. JM Friedman, PH Birch, Am J Med Genet 1997 70 2 138 43 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U 9128932 (Pubitemid 27184570)
14. Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients. EM-PJ Pasmant, P Lévy, I Laurendeau, N Ortonne, B Parfait, L Valeyrie-Allanore, K Leroy, P Wolkenstein, M Vidaud, D Vidaud, I Bièche, Mol Med 2011 17 79 87 20844836